Skip to content

Public FDA record

Z-0497-2025: Vue PACS Diagnostic Viewer with Vue PACS client 12.1.5 to 12.2.8.454 software Model Number: 1149418 Int

Recall record Z-0497-2025 for Philips Medical Systems Technologies Ltd.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0497-2025
Company in FDA record
Philips Medical Systems Technologies Ltd.
FDA classification date
Nov 20, 2024
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

A software issue affecting Philips Vue PACS may cause incorrect ischemic map and table value calculations when using the export function in the Perfusion Application for a Siemens CT perfusion study, resulting in misdiagnosis due to incorrect ischemic map and table values.

Source facts

Action
Philips issued URGENT Medical Device Correction letter(# 2024-EI-RI-001) via Fed'x on 10/10/24 to US consignees. Philips Markets organizations are responsible for distributing the letters outside of the U.S. Letter states reason for recall, health risk and action to take: To prevent the issue from occurring, Philips recommends that users not use the Perfusion Application Export function (as shown in Figure 4). When used without export functionality, the Perfusion Application performs as expected. " You may continue to use your system(s) in accordance with the intended use and by following the recommendation above. " If a study is reloaded in the Perfusion Application after an export action is performed, and the Perfusion/Diffusion Warning message is observed (shown in Figure 1), the ischemic map and table value calculations should not be used for diagnostic purposes. " Circulate this notice to all users of this device so that they are aware of the potential issue. Please retain this letter with your system(s) until a solution is installed on your system; ensure the letter is in a place likely to be seen/viewed. " Please complete and return the attached response form to Philips promptly and no later than 30 days from receipt of this letter via email to: EICnR@philips.com. 5. Actions planned by Philips to correct the problem A Philips representative will contact you to schedule a time to install a software solution on your system(s) to resolve the issue (reference FCO78000003). Philips plans to begin installing the solution on affected systems in October 2024. If you need any further information or support concerning this issue, please contact your local Philips representative: For North America, contact Informatics Customer Support (1-877-328-2808, Option 4).
Initiated
2024-10-10
Root cause
Software design
Distribution
US Nationwide and Worldwide Distribution Foreign: Country Argentina Australia Austria Belgium Brazil Chile China Colombia Denmark Finland France Germany Gibraltar Greece Guernsey Holy See (Vatican City State) Hong Kong Hungary Indonesia Ireland Israel Italy Japan Jersey Jordan Lebanon Malaysia Mexico Netherlands New Zealand Norway Oman Panama Philippines Poland Portugal Romania Saudi Arabia Serbia Slovenia Spain Sweden Switzerland Taiwan Thailand United Kingdom
Recall number
Z-0497-2025
Recall status
Open, Classified
CDRH record ID
210756
FDA classified
2024-11-20
Recall event number
95604

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗